Wegovy uses the same pen device as Ozempic but delivers the higher dose
patients seeking an on-label weight-management option are generally routed to Zepbound
[1] [3] According to the UK SmPC, dosing starts at 2.5 mg once weekly for 4 weeks, then increases in 2.5 mg increments every 4 weeks until the target dose (5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg) is reached, based on individual response and tolerability
Your healthcare provider should determine the most appropriate treatment approach and dosage based on the severity of diabetes
Morris MC, Schneider JA, Li H, Tangney CC, Nag S, Bennett DA et al
adults, or 15 million people, are diagnosed with MASH, according to the FDA